NICE Stock Price Target and Analyst Ratings (NASDAQ:NICE)

Analyst Price Target for NICE

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$288.83

▲ +25.83% Upside Potential

This price target is based on 12 analysts offering 12 month price targets for NICE in the last 3 months. The average price target is $288.83, with a high forecast of $338.00 and a low forecast of $254.00. The average price target represents a 25.83% upside from the last price of $229.54.

Buy

The current consensus among 12 investment analysts is to buy stock in NICE. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
9 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

9/6/2019

0 strong buy ratings
9 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

12/5/2019

0 strong buy ratings
9 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

3/4/2020

0 strong buy ratings
8 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

6/2/2020

0 strong buy ratings
7 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

8/31/2020

0 strong buy ratings
8 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

11/29/2020

0 strong buy ratings
8 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

1/28/2021

0 strong buy ratings
10 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

2/27/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
2/25/2021	Wedbush	Boost Price Target	Outperform	$275.00 ➝ $285.00	Medium	i
2/25/2021	Morgan Stanley	Boost Price Target	Overweight	$334.00 ➝ $338.00	Medium	i
2/19/2021	Wedbush	Boost Price Target	Outperform	$275.00 ➝ $285.00	High	i
2/19/2021	Pritchard Capital	Boost Price Target	Buy	$292.00 ➝ $312.00	High	i
2/19/2021	Royal Bank of Canada	Boost Price Target	Sector Perform	$250.00 ➝ $266.00	High	i
2/11/2021	Oppenheimer	Reiterated Rating	Outperform	$290.00	Low	i
1/29/2021	Barclays	Upgrade	Equal Weight ➝ Overweight	$246.00 ➝ $330.00	Low	i
12/17/2020	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$230.00 ➝ $334.00	Medium	i
12/9/2020	DA Davidson	Upgrade	Neutral ➝ Buy	$250.00 ➝ $275.00	Low	i
11/13/2020	Royal Bank of Canada	Boost Price Target	Sector Perform	$216.00 ➝ $250.00	High	i
11/13/2020	Wedbush	Boost Price Target	Outperform	$250.00 ➝ $275.00	High	i
11/13/2020	Rosenblatt Securities	Boost Price Target	Buy	$265.00 ➝ $290.00	High	i
11/13/2020	Morgan Stanley	Boost Price Target	Equal Weight	$212.00 ➝ $230.00	High	i
11/12/2020	Jefferies Financial Group	Boost Price Target	Buy	$265.00 ➝ $285.00	High	i
11/12/2020	JPMorgan Chase & Co.	Upgrade	Underweight ➝ Neutral	$210.00 ➝ $261.00	Low	i Rating by Paul Coster at JPMorgan Chase & Co.
11/3/2020	Bank of America	Initiated Coverage	Buy	$280.00	Medium	i
10/22/2020	Rosenblatt Securities	Boost Price Target	Buy	$260.00 ➝ $265.00	Low	i Rating by Ryan Koontz at Rosenblatt Securities
9/16/2020	Citigroup	Lower Price Target		$262.00 ➝ $254.00	Low	i
9/16/2020	Oppenheimer	Boost Price Target	Average ➝ Outperform	$230.00 ➝ $250.00	Low	i Rating by Shaul Eyal at Oppenheimer Holdings Inc.
8/11/2020	Oppenheimer	Reiterated Rating	Buy	$230.00	Low	i Rating by Shaul Eyal at Oppenheimer Holdings Inc.
8/7/2020	Morgan Stanley	Boost Price Target	Equal Weight	$156.00 ➝ $212.00	High	i
8/6/2020	Jefferies Financial Group	Boost Price Target	Buy	$195.00 ➝ $265.00	High	i
7/9/2020	Citigroup	Upgrade	Neutral ➝ Buy	$221.00	Low	i
6/26/2020	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$172.00	Low	i
6/24/2020	Wedbush	Boost Price Target		$200.00 ➝ $230.00	Low	i
6/18/2020	Oppenheimer	Boost Price Target	Positive ➝ Outperform	$180.00 ➝ $200.00	Medium	i Rating by Shaul Eyal at Oppenheimer Holdings Inc.
5/17/2020	Royal Bank of Canada	Reiterated Rating	Hold		Low	i
5/14/2020	Rosenblatt Securities	Reiterated Rating	Buy	$195.00	Medium	i Rating by Ryan Koontz at Rosenblatt Securities
5/14/2020	Oppenheimer	Reiterated Rating	Buy	$180.00	Medium	i Rating by Shaul Eyal at Oppenheimer Holdings Inc.
5/14/2020	Jefferies Financial Group	Boost Price Target	Buy	$180.00 ➝ $195.00	Medium	i
5/11/2020	Morgan Stanley	Boost Price Target	Equal Weight	$133.00 ➝ $144.00	Low	i
3/25/2020	Morgan Stanley	Lower Price Target	Equal Weight	$173.00 ➝ $133.00	Low	i
2/21/2020	Jefferies Financial Group	Boost Price Target	Buy	$179.00 ➝ $209.00	Medium	i
2/14/2020	Royal Bank of Canada	Boost Price Target	Market Perform	$182.00	Low	i
2/14/2020	Morgan Stanley	Boost Price Target	Equal Weight	$160.00 ➝ $173.00	Medium	i
2/14/2020	DA Davidson	Reiterated Rating	Positive ➝ Neutral	$175.00	Medium	i
2/14/2020	Citigroup	Boost Price Target	Neutral	$156.00 ➝ $193.00	Medium	i
2/14/2020	Rosenblatt Securities	Boost Price Target	Buy	$187.00 ➝ $195.00	Medium	i Rating by Ryan Koontz at Rosenblatt Securities
2/14/2020	Wedbush	Boost Price Target	Outperform	$185.00 ➝ $200.00	Medium	i
2/13/2020	Oppenheimer	Reiterated Rating	Buy	$193.00	Medium	i Rating by Shaul Eyal at Oppenheimer Holdings Inc.
1/27/2020	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$163.00	Low	i
11/27/2019	Oppenheimer	Boost Price Target	Outperform	$166.00 ➝ $170.00	Low	i Rating by Shaul Eyal at Oppenheimer Holdings Inc.
11/15/2019	Wedbush	Boost Price Target	Outperform	$165.00 ➝ $170.00	Low	i
11/15/2019	Rosenblatt Securities	Reiterated Rating	Buy	$187.00	Low	i Rating by Ryan Koontz at Rosenblatt Securities
10/15/2019	Oppenheimer	Set Price Target	Buy	$166.00	Low	i Rating by Shaul Eyal at Oppenheimer Holdings Inc.
9/4/2019	Rosenblatt Securities	Initiated Coverage	Buy	$187.00	Low	i
8/9/2019	Morgan Stanley	Set Price Target	Hold	$140.00	Low	i Rating by Meta Marshall at Morgan Stanley
8/9/2019	JMP Securities	Boost Price Target	Market Outperform	$164.00 ➝ $185.00	Low	i
8/9/2019	Jefferies Financial Group	Boost Price Target	Buy	$166.00 ➝ $179.00	Low	i
7/29/2019	JPMorgan Chase & Co.	Boost Price Target	Overweight	$150.00 ➝ $166.00	Low	i
5/17/2019	Citigroup	Boost Price Target	Neutral	$117.00 ➝ $137.00	Medium	i
5/17/2019	DA Davidson	Boost Price Target	Positive ➝ Neutral	$140.00	Low	i
5/17/2019	Morgan Stanley	Boost Price Target	Equal Weight	$117.00 ➝ $128.00	Low	i
5/17/2019	JMP Securities	Boost Price Target	Market Outperform	$140.00 ➝ $164.00	Low	i
5/16/2019	Jefferies Financial Group	Boost Price Target	Buy	$166.00	Low	i
5/16/2019	Wedbush	Reiterated Rating	Buy	$160.00	Low	i
4/24/2019	Barclays	Boost Price Target	Equal Weight ➝ Equal Weight	$124.00 ➝ $150.00	Low	i
4/22/2019	JMP Securities	Reiterated Rating	Outperform	$120.00 ➝ $140.00	High	i
4/22/2019	Wedbush	Reiterated Rating	Outperform ➝ Positive	$145.00 ➝ $155.00	High	i
4/18/2019	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$125.00 ➝ $150.00	Medium	i
4/17/2019	DA Davidson	Boost Price Target	Neutral ➝ Neutral	$110.00 ➝ $125.00	High	i
4/17/2019	Oppenheimer	Boost Price Target	Outperform ➝ Outperform	$125.00 ➝ $145.00	High	i
4/17/2019	Jefferies Financial Group	Boost Price Target	Buy	$134.00 ➝ $149.00	High	i
2/15/2019	Wedbush	Boost Price Target		$145.00	N/A	i
1/7/2019	Morgan Stanley	Boost Price Target	Equal Weight ➝ Equal Weight	$107.00 ➝ $117.00	Low	i
11/9/2018	Royal Bank of Canada	Boost Price Target	Market Perform	$120.00	Medium	i
10/18/2018	Wedbush	Initiated Coverage	Outperform ➝ Outperform	$130.00	Medium	i
9/20/2018	Jefferies Financial Group	Boost Price Target	Buy ➝ Buy	$132.00	Low	i
8/10/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$104.00 ➝ $110.00	Medium	i
8/10/2018	Barclays	Reiterated Rating	Neutral ➝ Hold	$114.00	Medium	i Rating by Tavy Rosner at Barclays PLC
6/22/2018	DA Davidson	Initiated Coverage	Neutral	$110.00	Low	i
5/16/2018	Jefferies Financial Group	Reiterated Rating	Buy	$119.00	Low	i
5/10/2018	Barclays	Set Price Target	Hold	$100.00	Low	i Rating by Tavy Rosner at Barclays PLC
5/8/2018	Morgan Stanley	Initiated Coverage	Equal ➝ Equal Weight	$101.00	Low	i Rating by Sanjit Singh at Morgan Stanley
2/21/2018	Chardan Capital	Reiterated Rating	Neutral ➝ Neutral	$91.00 ➝ $99.00	Low	i
2/18/2018	Barclays	Reiterated Rating	Hold	$93.00	High	i
1/18/2018	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$87.00	Medium	i
12/13/2017	Oppenheimer	Reiterated Rating	Buy	$90.00 ➝ $100.00	Low	i
12/13/2017	Citigroup	Reiterated Rating	Outperform	$90.00 ➝ $100.00	Medium	i
11/6/2017	Chardan Capital	Downgrade	Buy ➝ Neutral	$91.00	N/A	i
11/3/2017	Citigroup	Boost Price Target	Neutral	$83.00 ➝ $93.00	N/A	i
11/3/2017	Jefferies Financial Group	Boost Price Target	Hold	$84.00 ➝ $87.00	N/A	i
11/3/2017	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral		N/A	i
10/16/2017	Chardan Capital	Boost Price Target	Buy ➝ Buy	$84.00 ➝ $91.00	N/A	i
10/6/2017	Jefferies Financial Group	Initiated Coverage	Hold ➝ Hold	$84.00	N/A	i
8/21/2017	Royal Bank of Canada	Reiterated Rating	Hold	$80.00	Low	i
8/7/2017	Chardan Capital	Boost Price Target	Buy ➝ Buy	$76.00 ➝ $84.00	Low	i
8/7/2017	Barclays	Reiterated Rating	Hold		Low	i Rating by Tavy Rosner at Barclays PLC
8/4/2017	Barclays	Set Price Target	Hold	$75.00 ➝ $80.00	Low	i Rating by Tavy Rosner at Barclays PLC
8/4/2017	Oppenheimer	Boost Price Target	Outperform	$80.00 ➝ $85.00	Low	i
6/7/2017	Citigroup	Initiated Coverage	Neutral ➝ Neutral	$82.00	Low	i
5/12/2017	Oppenheimer	Reiterated Rating	Outperform	$80.00	Low	i
2/21/2017	Chardan Capital	Reiterated Rating	Buy		N/A	i Rating by Lena Rogovin at Chardan Capital
2/18/2017	Barclays	Set Price Target	Hold	$75.00	N/A	i Rating by Tavy Rosner at Barclays PLC
2/14/2017	Chardan Capital	Reiterated Rating	Buy	$76.00	N/A	i Rating by Lena Rogovin at Chardan Capital
2/10/2017	The Goldman Sachs Group	Initiated Coverage	Neutral	$76.00	N/A	i
1/13/2017	Imperial Capital	Downgrade	Outperform ➝ In-Line	$74.00 ➝ $76.00	N/A	i Rating by J. Kessler at Imperial Capital
1/11/2017	Chardan Capital	Boost Price Target	Buy	$72.00 ➝ $76.00	N/A	i Rating by Lena Rogovin at Chardan Capital
12/21/2016	Oppenheimer	Reiterated Rating	Outperform	$75.00	N/A	i
11/14/2016	Chardan Capital	Reiterated Rating	Buy	$72.00	N/A	i Rating by Lena Rogovin at Chardan Capital
11/11/2016	JMP Securities	Reiterated Rating	Buy		N/A	i Rating by greg mcdowell at JMP Securities
10/5/2016	Imperial Capital	Reiterated Rating	Outperform	$74.00	N/A	i
9/26/2016	Oppenheimer	Reiterated Rating	Outperform	$75.00	N/A	i Rating by Shaul Eyal at Oppenheimer Holdings Inc.
8/31/2016	JMP Securities	Reiterated Rating	Buy		N/A	i Rating by greg mcdowell at JMP Securities
7/28/2016	Chardan Capital	Boost Price Target	Buy	$70.00 ➝ $72.00	N/A	i
7/17/2016	Imperial Capital	Reiterated Rating	Outperform	$74.00	N/A	i
6/30/2016	JPMorgan Chase & Co.	Reiterated Rating	Buy		N/A	i Rating by Paul Coster at JPMorgan Chase & Co.
6/29/2016	JPMorgan Chase & Co.	Initiated Coverage	Overweight	$74.00	N/A	i
6/23/2016	Oppenheimer	Reiterated Rating	Buy	$75.00	N/A	i Rating by Shaul Eyal at Oppenheimer Holdings Inc.
6/22/2016	Chardan Capital	Initiated Coverage	Buy	$63.00	N/A	i
5/27/2016	UBS Group	Downgrade	Buy ➝ Neutral	$77.00 ➝ $70.00	N/A	i
5/26/2016	Oppenheimer	Reiterated Rating	Buy	$75.00	N/A	i Rating by Shaul Eyal at Oppenheimer Holdings Inc.
5/26/2016	JPMorgan Chase & Co.	Upgrade	Market Perform ➝ Outperform	$78.00	N/A	i
5/26/2016	JMP Securities	Upgrade	Market Perform ➝ Outperform	$78.00	N/A	i
5/18/2016	Oppenheimer	Reiterated Rating	Buy	$75.00	N/A	i

(Data available from 2/28/2016 forward)

NICE Ltd. provides enterprise software solutions worldwide. The company operates in two segments, Customer Engagement, and Financial Crime and Compliance. It offers CXone, a cloud native open platform that supports contact centers ranging from small single sites to distributed remote agents and enterprises; and a digital-first omnichannel customer engagement platform that supports various digital and self-service channels, which allows organizations to add and integrate new and emerging channels. The company also provides AI driven smarter processes and adaptive workforce engagement solutions. In addition, it offers NICE platform, a financial crime and compliance solution that handles various process, including detection, investigation, remediation, and reporting; and X-Sight, a cloud-based financial crime risk management platform-as-a-service. Further, the company provides professional service and support at various stages of the technology lifecycle, including defining requirements, planning, design, implementation, customization, optimization, maintenance, and ongoing support. It serves customers across various verticals, including banking, financial, telecommunications, healthcare, insurance, retail, travel, gaming, public safety, and state and local government. The company sells its solutions and products directly to customers, as well as indirectly through selected partners. NICE Ltd. has a strategic partnership with Information Services Group, Inc. to expand the automation ecosystem. The company was formerly known as NICE-Systems Ltd. and changed its name to NICE Ltd. in June 2016. NICE Ltd. was founded in 1986 and is based in Ra'anana, Israel.

Today's Range

Now: $229.54

$224.56

$231.93

50 Day Range

MA: $266.90

$228.44

$279.38

52 Week Range

Now: $229.54

$110.59

$288.73

Volume

463,123 shs

Average Volume

416,412 shs

Market Capitalization

$14.32 billion

P/E Ratio

74.05

Dividend Yield

N/A

Beta

0.76

Frequently Asked Questions

What sell-side analysts currently cover shares of NICE?

The following equities research analysts have issued stock ratings on NICE in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., DA Davidson, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., Pritchard Capital, Rosenblatt Securities, Royal Bank of Canada, Wedbush, and Zacks Investment Research.
View the latest analyst ratings for NICE.

What is the current price target for NICE?

12 Wall Street analysts have set twelve-month price targets for NICE in the last year. Their average twelve-month price target is $288.83, suggesting a possible upside of 25.8%. Morgan Stanley has the highest price target set, predicting NICE will reach $338.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $254.00 for NICE in the next year.
View the latest price targets for NICE.

What is the current consensus analyst rating for NICE?

NICE currently has 2 hold ratings and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NICE will outperform the market and that investors should add to their positions of NICE.
View the latest ratings for NICE.

What other companies compete with NICE?

Other companies that are similar to NICE include Dassault Systèmes, CrowdStrike, Veeva Systems, DocuSign, Palantir Technologies, Cadence Design Systems, Electronic Arts, Synopsys, Okta, Atlassian, ANSYS, Unity Software, Datadog, Coupa Software and HubSpot.

How do I contact NICE's investor relations team?

NICE's physical mailing address is 13 Zarchin Street P.O. Box 690, RA`ANANA L3, 4310602. The technology company's listed phone number is 972-9775-3151 and its investor relations email address is [email protected] The official website for NICE is www.nice.com.

NASDAQ:NICE - NICE Stock Price Target and Predictions

Analyst Price Target for NICE

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of NICE?

What is the current price target for NICE?

What is the current consensus analyst rating for NICE?

What other companies compete with NICE?

How do I contact NICE's investor relations team?